 |
BioWorld-International-2009-10-07
MHRA Lifts Hold on MediGene's RhuDex in RA; New Trial Likely
MHRA Lifts Hold on MediGene's RhuDex in RA; New Trial Likely
Almost 15 months after halting a Phase I trial of RhuDex following the death of a trial volunteer in Edinburgh, Scotland, the UK's Medicines and Healthcare products Regulatory Agency has lifted the clinical hold on the study. (BioWorld International)